3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Active not recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Neoplasms
5
Glioblastoma
4
Lung Neoplasms
3
Carcinoma, Hepatocellular
3
Brain Neoplasms
3
Urinary Bladder Neoplasms
2
Pancreatic Neoplasms
2
Glioma
2
Colorectal Neoplasms
2
Breast Neoplasms
2
Astrocytoma
2
Uterine Cervical Neoplasms
1
Thyroid Nodule
1
Stomach Neoplasms
1
Prostatic Neoplasms
1
Pleural Neoplasms
1
Pancreatic Cyst
1
Oropharyngeal Neoplasms
1
Mouth Neoplasms
1
Mesothelioma
1
Medication Adherence
1
Margins of Excision
1
Lymphedema
1
Lung Diseases
1
Liver Neoplasms
1
Laryngeal Neoplasms
1
Hypopharyngeal Neoplasms
1
Head and Neck Neoplasms
1
Esophageal Neoplasms
1
Early-stage Peripheral Non-small Cell Lung Cancer
1
Interventions
Oxaliplatin
290
Capecitabine
206
Fluorouracil
181
Cisplatin
168
Docetaxel
138
S 1 (combination)
132
Paclitaxel
121
Leucovorin
116
Irinotecan
106
pembrolizumab
103
Trastuzumab
71
apatinib
56
Nivolumab
56
sintilimab
45
Drug Therapy
43
Surgical Procedures, Operative
37
Radiotherapy
37
Bevacizumab
37
Ramucirumab
34
titanium silicide
31
Hyperthermic Intraperitoneal Chemotherapy
30
Epirubicin
30
Carboplatin
30
tislelizumab
28
Cyclophosphamide
27
XELOX
24
Tegafur
23
Folfox protocol
22
Albumin-Bound Paclitaxel
22
camrelizumab
21
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Stomach Neoplasms
×
Drug Delivery Systems
×
Clear all
NCT05899985
2026-04-06
MAGMAP
Ferronova Pty Ltd
Phase NA
Active not recruiting
60 enrolled